Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trialsJonathan I. Silverberg, Christophe Piketty, Andrew Pink et al.|The Lancet|2024Cited by 144